Oxidative Stress in the Amygdala Contributes to Neuropathic Pain

Area of Science:

• Neuroscience
• Pain Research
• Pharmacology

Background:

• The central nucleus of the amygdala (CeA) is implicated in neuropathic pain.
• Oxidative stress and TRPA1 channels are potential contributors to pain signaling.

Purpose of the Study:

• To investigate if antioxidants or TRPA1 antagonists in the CeA alleviate nociceptive and affective pain in experimental neuropathy.
• To determine the involvement of amygdaloid astrocytes and descending serotonergic pathways in this process.

Main Methods:

• Experiments were conducted in rats with spared nerve injury (SNI).
• Drugs were administered into the CeA or control sites, with intrathecal administration for spinal targets.
• Nociception was assessed using mechanical stimuli, and affective pain using conditioned place-aversion.

Main Results:

• Amygdaloid antioxidants or TRPA1 antagonists significantly reduced both nociceptive and affective pain in SNI rats.
• Astrogial modulation in the CeA did not affect pain, but local anesthesia did.
• A spinal 5-HT_1A receptor antagonist blocked the pain-relieving effects of amygdaloid TRPA1 blockers.

Conclusions:

• Injury-induced oxidative stress in the CeA, acting via TRPA1, promotes neuropathic pain behaviors.
• This pronociceptive effect involves the suppression of spinal 5-HT_1A receptor-mediated feedback inhibition.
• The CeA mediates nerve injury-induced pain, but its role in recruiting descending pain inhibition is less clear.